微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 35.86% | -12.57% | -6.23% | 100/159 | -2.82% | 海创药业 | 99.57% | 行业排名> |
| 2025-06-30 | 38.24% | -11.52% | -3.15% | 96/159 | 15.28% | 海创药业 | 99.52% | 行业排名> |
| 2025-03-31 | 39.48% | -9.37% | -2.64% | 96/159 | 32.3% | 艾力斯 | 96.74% | 行业排名> |
| 2024-12-31 | 40.55% | 1.79% | -1.12% | 101/159 | 51.78% | 首药控股 | 98.96% | 行业排名> |
| 2024-09-30 | 41.01% | 0.69% | -5.11% | 98/159 | 22.81% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 43.22% | 6.59% | -0.79% | 92/159 | 33.25% | 百利天恒 | 97.99% | 行业排名> |
| 2024-03-31 | 43.56% | 13.56% | 9.35% | 89/159 | 51.56% | 百利天恒 | 98.92% | 行业排名> |
| 2023-12-31 | 39.84% | 11.89% | -2.2% | 105/159 | 51.39% | 迈威生物 | 98.93% | 行业排名> |
| 2023-09-30 | 40.73% | 16.9% | 0.46% | 103/159 | 32.56% | 迈威生物 | 99.59% | 行业排名> |
| 2023-06-30 | 40.55% | 16.17% | 5.7% | 103/159 | 38.45% | 迈威生物 | 99.8% | 行业排名> |
| 2023-03-31 | 38.36% | 2% | 7.74% | 104/159 | 52.78% | 迈威生物 | 99.46% | 行业排名> |
| 2022-12-31 | 35.6% | -11.2% | 2.18% | 112/159 | 53.66% | 迈威生物 | 99.75% | 行业排名> |
| 2022-09-30 | 34.84% | 2% | -0.18% | 106/159 | 6.2% | 迈威生物 | 99.67% | 行业排名> |
| 2022-06-30 | 34.9% | -18.3% | -12.95% | 110/159 | 21.37% | 迈威生物 | 99.44% | 行业排名> |
| 2021-12-31 | 40.09% | -11.76% | -6.15% | 104/159 | 55.1% | 迈威生物 | 98.57% | 行业排名> |
| 2021-06-30 | 42.72% | 2% | -5.98% | 92/159 | 47.23% | 首药控股 | 99.93% | 行业排名> |
| 2020-12-31 | 45.44% | 11.97% | 11.97% | 94/159 | -145.9% | 艾力斯 | 99.41% | 行业排名> |
| 2019-12-31 | 40.58% | 72.54% | 72.54% | 99/159 | -1222.98% | 艾力斯 | 98.7% | 行业排名> |
| 2018-12-31 | 23.52% | 2% | 2% | 125/159 | -208.09% | 艾力斯 | 99.4% | 行业排名> |